Mubarik S,Wang F,Luo L,Hezam K,Yu C .2023 .Evaluation of Lee-Carter model to breast cancer mortality prediction in China and Pakistan. , 13 : 1101249.
Lukasiewicz S,Czeczelewski M,Forma A,Baj J,Sitarz R,Stanisławek A .2021 .Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review. Cancers, 13(17) : 4287.
Sohail SK,Sarfraz R,Imran M,Kamran M,Qamar S. Estrogen .2020 .and progesterone receptor expression in breast carcinoma and its association with clinicopathological variables among the pakistani population. Cureus, 12(8) : .
Khan R,Hashmi F,Bhatti AM,Memon AI .2023 .Locally Advanced Breast Cancer in Pakistani Women: Clinical Features and Prognostic Factors: Breast Cancer Prognostic Features. Pak J Health Sci, : 31-4.
Munawwar A,Sajjad A,Faisal S,Rasul A,Zarbab A,Bibi A,Study. Iran J Pub Health A Retrospective .2023 .Basic Findings of Incidence of Breast Cancer in Allied Hospital Faisalabad. , 52(6) : 1199.
Tufail M,Wu C .2023 .Exploring the Burden of Cancer in Pakistan: An Analysis of 2019 Data. J Epidemiol Global Health, : 1-11.
Zeeshan S,Ali B,Ahmad K,Chagpar AB,Sattar AK .2019 .Clinicopathological features of young versus older patients with breast cancer at a single Pakistani institution and a comparison with a national US database. J Global oncol, 5 : 1-6.
McGuire A,Brown JA,Malone C,McLaughlin R,Kerin MJ R .2015 .Effects of age on the detection and management of breast cancer. Cancers, 7(2) : 908-29.
Fatehi P,Mahboubi-Fooladi Z,Dastmardi M,Esfehani RJ,Bagheri AK .2023 .The correlation between imaging findings and breast cancer cell receptors status. J Med Imaging and Rad Sci, : .
Nasrazadani A,Thomas RA,Oesterreich S,Lee AV .2018 .Precision medicine in hormone receptor-positive breast cancer. Frontiers oncol, 8 : 144.
Wu J-R,Zhao Y,Zhou X-P,Qin X .2020 .Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis. Biomed & Pharmacotherapy, 121 : 109647.
Albert JM,Gonzalez-Angulo AM,Guray M,Sahin A,Strom EA,Tereffe W .2010 .Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer. International Journal of Radiation Oncology* Biology* Physics, 77(5) : 1296-302.
Furrer D,Paquet C,Jacob S,Diorio C. .2018 .The human epidermal growth factor receptor 2 (HER2) as a prognostic and predictive biomarker: Molecular insights into HER2 activation and diagnostic implications. Cancer prog, 5 : 11-21.
Motta JM,Hassan H,Ibrahim SA .2023 .Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma. Cancers, 15(6) : 1794.
Hu X,Chen W,Li F,Ren P,Wu H,Zhang C .2023 .Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance. Frontiers Oncol, 13 : 1053125.
Inwald E,Klinkhammer-Schalke M,Hofstädter F,Zeman F,Koller M,Gerstenhauer M .2013 .-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast can res treat, 139 : 539-52.
Badar F,Mahmood S,Faraz R,Yousaf A,Quader AU,Asif H .2015 .Epidemiology of breast cancer at the Shaukat Khanum memorial cancer hospital and research center, Lahore, Pakistan. J Coll Physicians Surg Pak, 25(10) : 738-42.
Lateef F,Jamal S,Nasir S .2017 .Invasive ductal carcinoma: correlation of immunophenotypic features with age. J Coll Physicians Surg Pak, 27(1) : 18-22.
Kang SY,Kim YS,Kim Z,Kim H-Y,Lee SK,Jung K-W .2018 .Basic findings regarding breast cancer in Korea in 2015: data from a breast cancer registry. J of breast can, 21(1) : 1-10.
Zeng H,Zheng R,Zhang S,Zou X,Chen W. .2014 .Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. J thorac dis, 6(5) : 466.
Benz CC .2008 .Impact of aging on the biology of breast cancer. Critical reviews in oncol/hematol, 66(1) : 65-74.
Siegel R,Ma J,Zou Z,Jemal A .2014 .a cancer journal for clinicians. , 64(1) : 9-29.
Kumar K,Akhtar M,Rangwala M. .2019 .Breast cancer: correlation of receptor status with clinical presentation, stage of disease, histopathological grade and short term outcome. Int Surg J, 6(4) : 1323-6.
Singh R,Gupta S,Pawar SB,Pawar RS,Gandham S,Prabhudesai S .2014 .Evaluation of ER, PR and HER-2 receptor expression in breast cancer patients presenting to a semi urban cancer centre in Western India. J can research and therapeutics., 10(1) : 26-8.
Hashmi AA,Aijaz S,Khan SM,Mahboob R,Irfan M,Zafar NI .2018 .Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients. World j surg oncol, 16 : 1-6.
Yang M,Sun J,Liu L,Kong X,Lin D,Zhou H .2023 .Clinicopathological characteristics of HER2-low breast cancer: a retrospective study. Scientific Reports, 13(1) : 12382.